To the Editor:
Osteonecrosis of the jaw associated with bisphosphonate use is an extremely rare but devastating complication. It is of interest to us that Yu, et al have shared our experience with the use of teriparatide in those who do not respond to conservative treatment. This case report and others1,2 suggest that there might be a role for the use of teriparatide in those with osteonecrosis of the jaw associated with bisphosphonate use.
